Abstract
Most chemical carcinogens are relatively inert and need metabolic activation to the ultimately carcinogenic species. The concentration of such species is controlled by several different enzymes. Especially well studied is the important group of enzymes responsible for the control of reactive epoxides. Many natural, as well as man-made foreign compounds, including pharmaceuticals, possess olefinic or aromatic double bonds. Such compounds can be transformed to epoxides by microsomal monooxygenases present in many mammalian organs. By virtue of their electrophilic reactivity, such epoxides may spontaneously react with nucleophilic centres in the cell and thus covalently bind to DNA, RNA and protein. Such alterations of critical cellular macromolecules may disturb the normal biochemistry of the cell and lead to cytotoxic, allergic and/or carcinogenic effects. Whether such effects will be manifested depends on one hand, on the chemical reactivity as well as other properties such as geometry and lipophilicity of the epoxide in question. On the other hand, enzymes controlling the concentration of such epoxides represent a further important contributing factor: for example, several microsomal monooxygenases exist, differing in substrate specificity. With respect to large substrates, certain monooxygenases preferentially attack at a specific site different from that attacked by others. Some of these pathways lead to reactive products, whilst others are detoxification pathways. Moreover, enzymes metabolizing such epoxides represent a further determining factor. These enzymes include epoxide hydrolases and glutathione transferases. These enzymes are not solely inactivating but can also in some cases act as activating enzymes. Finally, precursor-sequestering enzymes contribute indirectly but substantially to the control of reactive metabolites. All these enzymes differ in quantity, subcellular localization and sometimes also in substrate specificity between organs, development stages, sexes and species. They therefore represent an important contributing factor to differences in susceptibilities. Further factors responsible for differences in susceptibilities include DNA repair capabilities, rate of replicative DNA synthesis and various host defense mechanisms.
Similar content being viewed by others
References
Bentley P, Oesch F (1975) Purification of rat liver epoxide hydratase to apparent homogeneity. FEBS Lett 59: 291–295
Bentley P, Schmassmann HU, Sims P, Oesch F (1976) Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase: A general assay and kinetic properties. Eur J Biochem 69: 97–103
Bentley P, Oesch F, Glatt HR (1977) Dual role of epoxide hydratase in both activation and inactivation. Arch Toxicol 39: 65–75
Cooper CS, MacNicoll AD, Ribeiro O, Gervasi GP, Hewer A, Walsh C, Pal K, Grover PL (1980) The involvement of a non- “bay-region” diol-epoxide in the metabolic activation of benz(a)anthracene in hamster embryo cells. Cancer Lett 9: 53–59
Friedberg T, Milbert U, Bentley P, Guenthner TM, Oesch F (1983) Purification and characterization of a new cytosolic glutathione S-transferase (glutathione S-transferase X) from rat liver. Biochem J 215: 617–625
Gilham B (1971) The reaction of aralkyl sulphate esters with glutathione catalysed by rat liver preparations. Biochem J 121: 667–672
Glatt HR, Oesch F (1977) Inactivation of electrophilic metabolites by glutathione transferases and limitation of the system due to subcellular localization. Arch Toxicol 39: 87–96
Glatt HR, Vogel K, Bentley P, Oesch F (1979) Reduction of benzo(a)pyrene mutagenicity by dihydrodiol dehydrogenase. Nature 277: 319–320
Glatt HR, Billings R, Platt KL, Oesch F (1981) Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate. Cancer Res 41: 270–277
Glatt HR, Cooper CS, Grover PL, Sims P, Benteley P, Mertes M, Waechter F, Vogel K, Guenthner TM, Oesch F (1982) Inactivation of a diol-epoxide by dihydrodiol dehydrogenase, but not by two epoxide hydrolases. Science 215: 1507–1509
Glatt HR, Friedberg T, Grover PL, Sims P, Oesch F (1983) Inactivation of a diol-epoxide and a K-region epoxide by glutathione S-transferases: High efficiency of the new form X. Cancer Res 43: 5713–5717
Guenthner TM, Jernström B, Orrenius S (1980) On the effect of cellular nucleophiles on the binding of metabolites of 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene and 9-hydroxy-benzo(a)pyrene to nuclear DNA. Carcinogenesis 1: 407–418
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139
Hecht SS, LaVoie E, Mazzorese R, Amin S, Bedenko V, Hoffmann D (1978) 1,2-Dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene. Cancer Res 38: 2191–2198
Huberman E, Sachs L, Yang SK, Gelboin HV (1976) Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci USA 73: 607–611
Jakoby WB, Ketley JN, Habig WH (1976) Rat glutathione S- transferases: binding and physical properties. In: Arias I, Jakoby W (eds) Glutathione: metabolism and function, vol 6. Raven Press, New York, p 213
Jerina DM, Dansette PM, Lu AYH, Levin W (1977) Hepatic microsomal epoxide hydrolase: a sensitive radiometric assay for hydration of arena oxides of carcinogenic aromatic hydrocarbons. Mol Pharmacol 13: 342–351
Kapitulnik J, Wislocki PG, Levin W, Yagi H, Jerina DM, Conney AH (1978a) Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (±)-trans-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. Cancer Res 38: 354–358
Kapitulnik J, Wislocki PG, Levin W, Yagi H, Thakker DR, Akagi H, Koreeda M, Jerina DM, Conney AH (1978b) Marked differences in the carcinogenic activity of optically pure (±)- and (−)-trans-7,8-dihydrobenzo(a)pyrene in newborn mice. Cancer Res 38: 2661–2665
Lehr RE, Jerina DM (1977) Metabolic activation of polycyclic hydrocarbons. Structure-activity relationships. Arch Toxicol 39: 1–6
Levin W, Wood AW, Wislocki PG, Chang RL, Kapitulnik J, Mah HD, Yagi H, Jerina DM, Conney AH (1978) Mutagenicity and carcinogenicity of benzo(a)pyrene and benzo(a)pyrene derivatives. In: Gelboin HV, Ts'o POP (eds) Polycyclic hydrocarbons and cancer, Vol 1. Academic Press, New York, p 189
MacNicoll AD, Cooper CS, Ribeiro O, Pal K, Hewer A, Grover PL, Sims P (1981) The metabolic activation of benz(a)anthracence in three biological systems. Cancer Lett 11: 243–249
Malaveille C, Kuroki T, Sims P, Grover PL, Bartsch H (1977) Mutagenicity of isomeric diol-epoxides of benzo(a)pyrene and benz(a)anthracene in S. typhimurium TA98 and TA100 and in V79 Chinese hamser cells. Mutat Res 44: 313–326
Newbold RF, Brookes P (1976) Exceptional mutagenicity of benzo(a)pyrene diol epoxide in cultured mammalian cells, Nature 261: 52–54
Oesch F (1973) Mammalian epoxide hydrases: Inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305–340
Oesch F (1974) Purification and specificity of a microsomal human epoxide hydratase. Biochem J 139: 77–88
Oesch F (1976) Differntial control of rat microsomal “aryl hydrocarbon” monooxygenase and epoxide hydratase. J Biol Chem 251: 79–87
Oesch F (1979) Enzymes as regulators of toxic reactions by electrophilic metabolites. Arch Toxicol Suppl 2: 215–227 In: Chambers PL, Günzel P (eds) Mechanism of toxic action on some target organs. Springer Berlin Heidelberg New York p 215
Oesch F, Glatt HR (1976) Evaluation of the relative importance of various enzymes involved in the control of mutagenic and cytotoxic metabolites. In: Montesano R (ed) Tests in chemical carcinogenesis. IARC Scientific Publications No 12. nternational Agency for Research on Cancer, Lyon, p 255
Sims P, Grover PL, Swaisland A, Pal K, Hewer A (1974) Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 25: 226–228
Slaga TJ, Viaje A, Berry DL, Bracken WM, Buty SG, Scribner JD (1976) Skin-tumor initiating ability of benzo(a)pyrene 4,5-, 7,8-diol and 7,8-diol-9,10-epoxides. Cancer Lett 2: 115–122
Slaga TJ, Viaje A, Bracken WM, Berry DL, Fischer SM, Miller DR, Leclerc SM (1977) Skin-tumor-initiating ability of benzo(a)pyrene-7,8-diol-9,10-epoxide (anti) when applied topically in tetrahydrofuran. Cancer Lett 3: 23–30
Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, Conney AH (1979) Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-oxides. Cancer Res 39: 67–71
Stasiecki P, Oesch F, Bruder G, Jarasch ED, Franke WW (1980) Distribution of enzymes involved in metabolism of polydyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes. Eur J Cell Biol 21: 79–92
Vigny P, Kindts M, Duquesne M, Cooper CS, Grover PL, Sims P (1980) Metabolic activation of benz(a)anthracene: fluorescence spectral evidence indicates the involvement of a non- “bay-region” diol epoxide. Carcinogenesis 1: 33–41
Wislocki PG, Wood AW, Chang RL, Levin W, Yagi H, Hernandez O, Jerina DM, Conney AH (1976) High mutagenicity and toxicity of a diol epoxide derived from benzo(a)pyrene. Biochem Biophys Res Commun 68: 1006–1012
Wood AW, Levin W, Lu AYH, Yagi H, Hernandez O, Jerina DM, Conney AH (1976) Metabolism of benzo(a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J Biol Chem 251: 4882–4890
Wood AW, Chang RL, Levin W, Lehr RE, Schaefer-Ridder M, Karle JM, Jerina DM, Conney AH (1977) Mutagenicity and cytotoxicity of benz(a)anthracene diol epoxides and tetrahydro-epoxides: exceptional activity of the bay region 1,2-epoxides. Proc Natl Acad Sci USA 74: 2746–2750
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Oesch, F. Significance of various enzymes in the control of reactive metabolites. Arch Toxicol 60, 174–178 (1987). https://doi.org/10.1007/BF00296975
Issue Date:
DOI: https://doi.org/10.1007/BF00296975